Acute toxicity comparison of magnetic resonance‐guided adaptive versus fiducial or computed tomography‐guided non‐adaptive prostate stereotactic body …

JE Leeman, KY Shin, YH Chen, RH Mak, PL Nguyen… - Cancer, 2023 - Wiley Online Library
Background Stereotactic body radiotherapy (SBRT) is gaining wider adoption for prostate
cancer management but there remain significant toxicity risks when delivering prostate …

[HTML][HTML] Magnetic resonance imaging–guided focal boost to intraprostatic lesions using external beam radiotherapy for localized prostate cancer: a systematic review …

DMC Poon, J Yuan, B Yang, LGW Kerkmeijer… - European Urology …, 2023 - Elsevier
Context It is anticipated that a focal boost to intraprostatic lesions (IPLs) using external beam
radiotherapy (EBRT) guided by magnetic resonance imaging (MRI) will increase …

A pilot study of MRI radiomics for high‐risk prostate cancer stratification in 1.5 T MR‐guided radiotherapy

Y Zhou, J Yuan, C Xue, DMC Poon… - Magnetic …, 2023 - Wiley Online Library
Purpose To investigate the potential value of MRI radiomics obtained from a 1.5 T MRI‐
guided linear accelerator (MR‐LINAC) for D'Amico high‐risk prostate cancer (PC) …

A prospective study of Stereotactic Body Radiotherapy (SBRT) with concomitant Whole-Pelvic Radiotherapy (WPRT) for high-risk localized prostate cancer patients …

DMC Poon, J Yuan, B Yang, OL Wong, ST Chiu… - Cancers, 2022 - mdpi.com
Simple Summary Magnetic resonance (MR)-guided stereotactic body radiotherapy
(MRgSBRT) with concomitant whole-pelvic nodal radiotherapy (WPRT) represents a novel …

Analysis of online plan adaptation for 1.5 T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer

DMC Poon, B Yang, H Geng, OL Wong, ST Chiu… - Journal of Cancer …, 2023 - Springer
Purpose To analyze and characterize the online plan adaptation of 1.5 T magnetic
resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer (PC) …

Que faut-il pour faire de la radiothérapie adaptative «online»?

G Delpon, A Barateau, A Beneux, I Bessières… - Cancer …, 2022 - Elsevier
Résumé Lors de la session commune de la Société Française de Radiothérapie
Oncologique (SFRO) et de la Société française de physique médicale (SFPM) du congrès …

Photon vs proton hypofractionation in prostate Cancer: A systematic review and meta-analysis

G Corrao, G Marvaso, F Mastroleo, A Biffi… - Radiotherapy and …, 2024 - Elsevier
Background High-level evidence on hypofractionated proton therapy (PT) for localized and
locally advanced prostate cancer (PCa) patients is currently missing. The aim of this study is …

Assessment of planning target volume margins in 1.5 T magnetic resonance‐guided stereotactic body radiation therapy for localized prostate cancer

B Yang, J Yuan, DMC Poon, H Geng… - Precision Radiation …, 2022 - Wiley Online Library
Objective We aimed to determine the planning target volume margins applicable to
magnetic resonance‐guided stereotactic body radiation therapy (MRgSBRT) of localized …

Patient reported outcomes following MR-guided radiotherapy for prostate cancer: a systematic review and meta-analysis

JM Westerhoff, TA Lalmahomed, L Meijers… - International Journal of …, 2024 - Elsevier
Purpose This systematic review provides an overview of literature on the impact of MR-
guided radiotherapy (MRgRT) on patient reported outcomes (PROs) in patients with prostate …

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer

DMC Poon, J Yuan, OL Wong, B Yang, MY Tse… - World Journal of …, 2024 - Springer
Background and purpose This prospective study aimed to investigate adaptive magnetic
resonance (MR)-guided stereotactic body radiation therapy (MRgSBRT) with rectal spacer …